The Magpie Trial [1] (multiple letters)

Lancet

Volumn 360, Issue 9342, 2002, Pages 1329-1332

  Sibai, Baha M ^a   Walters, Barry N J ^b   Graham, Dorothy ^c   Hamilton, Dale ^c   Mittendorf, Robert ^d   Pryde, Peter G ^e   Herschel, Marguerite ^e   Lee, Kwang Sun ^e   Weeks, Andrew D ^f   Ononge, Samuel ^f   Guidotti, Richard ^g   Duley, Lelia ^h   Carroli, Guillermo ^h   Farrell, Barbara ^h   Moodley, Jack ^h   Neilson, Jim ^h  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f MAKERERE UNIVERSITY   (Uganda)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE; PLACEBO;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEATH; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOTENSION; INJECTION SITE; LETTER; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PERINATAL MORTALITY; PREECLAMPSIA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SEIZURE; SIDE EFFECT; SURVIVAL; TOCOLYSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; CONTROLLED CLINICAL TRIAL; ECLAMPSIA; FEMALE; NOTE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ANTICONVULSANTS; ECLAMPSIA; FEMALE; HUMANS; MAGNESIUM SULFATE; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS;

EID: 0037180249     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11321-3     Document Type: Letter

References (0)